BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 9888185)

  • 1. Quantitation of tazemetostat in human plasma using liquid chromatography-tandem mass spectrometry.
    Orleni M; Parise RA; Holleran JL; Amengual JE; Feng Y; Synold T; Beumer JH
    Biomed Chromatogr; 2024 May; ():e5903. PubMed ID: 38783541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Validated Bioanalytical HPLC-UV Method for Simultaneous Estimation of Amlodipine and Atorvastatin in Rat Plasma.
    Talele GS; Porwal PK
    Indian J Pharm Sci; 2015; 77(6):742-50. PubMed ID: 26997703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting.
    Moradi O; Karimzadeh I; Davani-Davari D; Shafiekhani M; Sagheb MM; Raees-Jalali GA
    Int J Organ Transplant Med; 2020; 11(4):185-195. PubMed ID: 33335699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantitation of atorvastatin and its two active metabolites in human plasma by liquid chromatography/(-) electrospray tandem mass spectrometry.
    Partani P; Verma SM; Gurule S; Khuroo A; Monif T
    J Pharm Anal; 2014 Feb; 4(1):26-36. PubMed ID: 29403866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of atorvastatin, metformin and glimepiride in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.
    Polagani SR; Pilli NR; Gajula R; Gandu V
    J Pharm Anal; 2013 Feb; 3(1):9-19. PubMed ID: 29403791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of a novel potentiometric membrane sensor for determination of atorvastatin in pharmaceutical preparations.
    Ahmadi F; Asaadi N
    Iran J Pharm Res; 2013; 12(4):645-57. PubMed ID: 24523744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress Degradation Behavior of Atorvastatin Calcium and Development of a Suitable Stability-Indicating LC Method for the Determination of Atorvastatin, its Related Impurities, and its Degradation Products.
    Vukkum P; Moses Babu J; Muralikrishna R
    Sci Pharm; 2013; 81(1):93-114. PubMed ID: 23641331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous Determination of Atorvastatin and Aspirin in Human Plasma by LC-MS/MS: Its Pharmacokinetic Application.
    Gajula R; Pilli NR; Ravi VB; Maddela R; Inamadugu JK; Polagani SR; Busa S
    Sci Pharm; 2012; 80(4):923-40. PubMed ID: 23264940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability Indicating RP-HPLC Estimation of Atorvastatin Calcium and Amlodipine Besylate in Pharmaceutical Formulations.
    Shah DA; Bhatt KK; Mehta RS; Baldania SL; Gandhi TR
    Indian J Pharm Sci; 2008 Nov; 70(6):754-60. PubMed ID: 21369436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ultra high performance liquid chromatography-tandem mass spectrometry to demonstrate decreased serum statin levels after extracorporeal LDL-cholesterol elimination.
    Bláha M; Vlcková H; Nováková L; Solichová D; Solich P; Lánská M; Malý J; Bláha V
    J Biomed Biotechnol; 2011; 2011():912472. PubMed ID: 21076535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.
    Wilke RA; Lin DW; Roden DM; Watkins PB; Flockhart D; Zineh I; Giacomini KM; Krauss RM
    Nat Rev Drug Discov; 2007 Nov; 6(11):904-16. PubMed ID: 17971785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated HPLC/MS/MS assay for CI-1011 in rat plasma and a comparison with an HPLC/UV assay.
    Bullen WW; Lathia CD; Abel RB; Hayes RN
    J Pharm Biomed Anal; 1998 Sep; 17(8):1399-413. PubMed ID: 9800659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a liquid chromatography-tandem mass spectrometry method for simultaneous determination of amlodipine, atorvastatin and its metabolites ortho-hydroxy atorvastatin and para-hydroxy atorvastatin in human plasma and its application in a bioequivalence study.
    Zhou Y; Li J; He X; Jia M; Liu M; Li H; Xiong Z; Fan Y; Li W
    J Pharm Biomed Anal; 2013 Sep; 83():101-7. PubMed ID: 23711572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry.
    Jemal M; Ouyang Z; Chen BC; Teitz D
    Rapid Commun Mass Spectrom; 1999; 13(11):1003-15. PubMed ID: 10368976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin: A Review of Analytical Methods for Pharmaceutical Quality Control and Monitoring.
    Kogawa AC; Pires AEDT; Salgado HRN
    J AOAC Int; 2019 May; 102(3):801-809. PubMed ID: 30563586
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma.
    Bullen WW; Miller RA; Hayes RN
    J Am Soc Mass Spectrom; 1999 Jan; 10(1):55-66. PubMed ID: 9888185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a sensitive, simple, and rapid method for simultaneous quantitation of atorvastatin and its acid and lactone metabolites by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
    Macwan JS; Ionita IA; Dostalek M; Akhlaghi F
    Anal Bioanal Chem; 2011 Apr; 400(2):423-33. PubMed ID: 21359569
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.